TREM2 and Alzheimer disease: In addition, TREM2 (triggering receptor expressed on myeloid cells 2) and CD33 receptors have also been found to be associated with the microglial immune response and pathogenesis of AD (Yeh et al., 2017; Griciuc et al., 2019).